ProPhase Labs, Inc. Inventory, Work in Process, Gross
ProPhase Labs, Inc. (PRPH) had Inventory, Work in Process, Gross of $0 as of 2025-12-31, per its 10-K filed 2026-06-01.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryWorkInProcess · last filed 2026-06-01
- 2025-12-31: Inventory, Work in Process, Gross $0.00.
- 2024-12-31: Inventory, Work in Process, Gross $65.00K.
- 2023-12-31: Inventory, Work in Process, Gross $119.00K; Inventory, Work in Process, Gross as first filed $306.00K.
- 2022-12-31: Inventory, Work in Process, Gross $754.00K.
| Period end | Inventory, Work in Process, Gross | Inventory, Work in Process, Gross as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-06-01 | |
| 2024-12-31 | $65.00K 10-K · filed 2026-06-01 | |
| 2023-12-31 | $119.00K 10-K · filed 2025-04-01 | $306.00K 10-K · filed 2024-03-29 |
| 2022-12-31 | $754.00K 10-K · filed 2024-03-29 | |
| 2022-09-30 | $609.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $676.00K 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $476.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $260.00K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $407.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $345.00K 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $185.00K 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $440.00K 10-K · filed 2022-03-31 | $437.00K 10-K · filed 2021-03-31 |
| 2020-09-30 | $381.00K 10-Q · filed 2020-11-19 | |
| 2020-06-30 | $350.00K 10-Q · filed 2020-08-11 | |
| 2020-03-31 | $463.00K 10-Q · filed 2020-05-12 | |
| 2019-12-31 | $299.00K 10-K · filed 2021-03-31 | |
| 2019-09-30 | $462.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $452.00K 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $243.00K 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $371.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | $333.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $466.00K 10-Q · filed 2018-08-20 | |
| 2018-03-31 | $258.00K 10-Q/A · filed 2018-08-20 | |
| 2017-12-31 | $245.00K 10-K · filed 2019-03-26 | |
| 2017-09-30 | $366.00K 10-Q/A · filed 2018-08-20 | |
| 2017-06-30 | $342.00K 10-Q/A · filed 2018-08-20 | |
| 2017-03-31 | $438.00K 10-Q/A · filed 2018-08-20 | |
| 2016-12-31 | $466.00K 10-Q/A · filed 2018-08-20 | |
| 2016-09-30 | $291.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $246.00K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $299.00K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $530.00K 10-K · filed 2017-02-24 | |
| 2015-09-30 | $408.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $234.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $207.00K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $418.00K 10-K · filed 2016-03-29 | |
| 2013-12-31 | $164.00K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |